Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance

NCT02526797 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-02-28

No results posted yet for this study

Summary

To investigate whether multiparametric MRI (mp-MRI) in patients with low-risk prostate cancer can improve the selection of patients suitable for Active Surveillance and have a relevance in the ongoing monitoring.

Conditions

  • Prostatic Neoplasms

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Lars Boesen, MD, PhD · Department of Urology, Herlev University Hospital Herlev, Herlev, Denmark, 2730

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2026-07-31
Completion
2026-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02526797 on ClinicalTrials.gov